Richa Chibbar
Lakeridge Health
Internal medicineOncologyRandomized controlled trialCohort studyFollicular lymphomaChronic lymphocytic leukemiaDiffuse large B-cell lymphomaLymphoma2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Convalescent plasmaLength of hospitalizationWeb of scienceMedicineCohortRelative riskMeta-analysis
Publications 2
#1Charan Thej Reddy Vegivinti (Manipal University)H-Index: 1
#2John M. PedersonH-Index: 2
Last. Ameer E. HassanH-Index: 1
view all 28 authors...
The purpose of this systematic review and meta-analysis was to examine clinical outcomes associated with convalescent plasma therapy in COVID-19 patients. We performed a literature search on PubMed, medRxiv, Web of Science, and Scopus to identify studies published up to December 10th, 2020 that examined the efficacy of convalescent plasma treatment for COVID-19. The primary endpoints were mortality, clinical improvement, and hospital length of stay. We screened 859 studies that met the search cr...
3 CitationsSource
#1Gwynivere A. Davies (HHS: Hamilton Health Sciences)
#1Gwynivere A. Davies (HHS: Hamilton Health Sciences)
Last. Adam A. Dmytriw (U of T: University of Toronto)H-Index: 14
view all 5 authors...
The literature suggests an increased risk between anthropometrics including higher body mass index and lymphoma incidence; however, the association with physical activity remains unclear. A systematic review/meta-analysis was therefore performed to examine this association with physical activity (total, recreational or occupational). PubMed, Web of Science and Embase were reviewed from inception to October 2019 identifying relevant observational studies. Non-Hodgkin lymphoma (NHL) including subt...